Website intended for a New Zealand health professional readership +News Goodfellow Symposium 2026 Watch out for vision loss in patients taking GLP-1 agonists, CARM warns Wednesday 8 April 2026, 03:58 PM New Zealands Centre for Adverse Reactions Monitoring has received reports of persistent visual loss in patients taking GLP-1 agonists [Image: engin akyurt on Unsplash] News archive How to Treat FREE READ Age-related macular degeneration Ophthalmologists John Ah-Chan and Andrew Thompson discuss how to identify age-related macular degeneration, when to refer to a specialist and eye health recommendations for patients
In addition to, studies have demonstrated that GLP-1RAs have cardioprotective and anti-fibrotic effects that extend beyond glycemic control
The supplement combines four clinically researched ingredients, CQR-300, Ceylon Cinnamon Extract, Eriocitrin, and Chromium Picolinate, to curb cravings, boost metabolism, and enhance GLP-1 activity
Consequently, individuals with normal or near-normal BMI are now seeking semaglutide to shed a few kilos without any underlying medical indication